{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:07:14Z","timestamp":1761005234526,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.annepidem.2019.12.004","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T12:48:18Z","timestamp":1575636498000},"page":"7-13.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes"],"prefix":"10.1016","volume":"41","author":[{"given":"Jingchuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley I.","family":"Naimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Muldoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Costacou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.annepidem.2019.12.004_bib1","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","article-title":"Type 1 diabetes and coronary artery disease","volume":"29","author":"Orchard","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc19-1214","article-title":"A contemporary estimate of total mortality and cardiovascular disease risk in young adults with type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study","volume":"39","author":"Miller","year":"2016","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.annepidem.2019.12.004_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N\u00a0Engl J Med"},{"year":"2015","series-title":"IDF Diabetes Atlas","key":"10.1016\/j.annepidem.2019.12.004_bib4"},{"issue":"20","key":"10.1016\/j.annepidem.2019.12.004_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.004_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00403306","article-title":"Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria","volume":"39","author":"Group","year":"1996","journal-title":"Diabetologia"},{"issue":"9068","key":"10.1016\/j.annepidem.2019.12.004_bib7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(96)10244-0","article-title":"Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.annepidem.2019.12.004_bib8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2337\/diacare.23.12.1823","article-title":"Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial","volume":"23","author":"O\u2019Hare","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.004_bib9","first-page":"123","article-title":"Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function","volume":"27","author":"Poulsen","year":"2001","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.annepidem.2019.12.004_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8227(01)00289-3","article-title":"Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM)","volume":"55","author":"Katayama","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.annepidem.2019.12.004_bib11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.004_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.annepidem.2019.12.004_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"Supplement 1","key":"10.1016\/j.annepidem.2019.12.004_bib14","first-page":"S86","article-title":"9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.annepidem.2019.12.004_bib15","doi-asserted-by":"crossref","first-page":"i438","DOI":"10.1136\/bmj.i438","article-title":"Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials","volume":"352","author":"Bangalore","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.004_bib16","doi-asserted-by":"crossref","first-page":"e1001971","DOI":"10.1371\/journal.pmed.1001971","article-title":"Cardiovascular and renal outcomes of renin\u2013angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses","volume":"13","author":"Catal\u00e1-L\u00f3pez","year":"2016","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.004_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","author":"Nathan","year":"2016","journal-title":"Diabetes"},{"issue":"2007","key":"10.1016\/j.annepidem.2019.12.004_bib18","first-page":"273","article-title":"ACE-I\/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification","volume":"21","author":"Maahs","year":"2017","journal-title":"J\u00a0Diabetes Complications"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.004_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.004_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D","article-title":"Modern statistical techniques for the analysis of longitudinal data in biomedical research","volume":"30","author":"Edwards","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.annepidem.2019.12.004_bib21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2337\/diab.39.9.1116","article-title":"Prevalence of complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complications study II","volume":"39","author":"Orchard","year":"1990","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.annepidem.2019.12.004_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diab.31.2.136","article-title":"The Pittsburgh study of insulin-dependent diabetes mellitus. risk for diabetes among relatives of IDDM","volume":"31","author":"Wagener","year":"1982","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.annepidem.2019.12.004_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0091-7435(76)90039-6","article-title":"The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group","volume":"5","author":"Borhani","year":"1976","journal-title":"Prev Med"},{"issue":"11","key":"10.1016\/j.annepidem.2019.12.004_bib24","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s00125-007-0797-7","article-title":"Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh epidemiology of diabetes complications study (EDC)","volume":"50","author":"Prince","year":"2007","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.004_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.004_bib26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/clinchem\/19.5.476","article-title":"Quantitative determination of serum triglycerides by the use of enzymes","volume":"19","author":"Bucolo","year":"1973","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.annepidem.2019.12.004_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/clinchem\/24.6.900","article-title":"Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples","volume":"24","author":"Warnick","year":"1978","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.annepidem.2019.12.004_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.004_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0272-6386(89)80039-3","article-title":"Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus","volume":"13","author":"Ellis","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.004_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1037\/a0029311","article-title":"Assessing mediation using marginal structural models in the presence of confounding and moderation","volume":"17","author":"Coffman","year":"2012","journal-title":"Psychol Methods"},{"issue":"2","key":"10.1016\/j.annepidem.2019.12.004_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ppe.12443","article-title":"The role of preterm birth in the association between opioid maintenance therapy and neonatal abstinence syndrome","volume":"32","author":"Lemon","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.004_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwv329","article-title":"Mediation analysis for health disparities research","volume":"184","author":"Naimi","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.004_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","article-title":"Time-dependent covariates in the Cox proportional-hazards regression model","volume":"20","author":"Fisher","year":"1999","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.annepidem.2019.12.004_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.004_bib35","doi-asserted-by":"crossref","first-page":"e0198132","DOI":"10.1371\/journal.pone.0198132","article-title":"Using time-varying models to estimate post-transplant survival in pediatric liver transplant recipients","volume":"13","author":"Bryce","year":"2018","journal-title":"PLoS One"},{"author":"Therneau","key":"10.1016\/j.annepidem.2019.12.004_bib36"},{"author":"Terry","key":"10.1016\/j.annepidem.2019.12.004_bib37"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.004_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.annepidem.2019.12.004_bib39","first-page":"219","article-title":"Marginal structural cox models for estimating the association between \u03b2-interferon exposure and disease progression in a multiple sclerosis cohort","volume":"24","author":"Penson","year":"2016","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.annepidem.2019.12.004_bib40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.annepidem.2019.12.004_bib41","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/oby.21621","article-title":"Prepregnancy obesity and the racial disparity in infant mortality","volume":"24","author":"Lemon","year":"2016","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.004_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/aje\/kwr525","article-title":"A\u00a0simple unified approach for estimating natural direct and indirect effects","volume":"176","author":"Lange","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2019.12.004_bib43","doi-asserted-by":"crossref","first-page":"e2017035","DOI":"10.4178\/epih.e2017035","article-title":"Applied mediation analyses: a review and tutorial","volume":"39","author":"Lange","year":"2017","journal-title":"Epidemiol Health"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.004_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.004_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"year":"2004","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","key":"10.1016\/j.annepidem.2019.12.004_bib46"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.004_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12955-019-1181-2","article-title":"Impact of missing data on bias and precision when estimating change in patient-reported outcomes from a clinical registry","volume":"17","author":"Ayilara","year":"2019","journal-title":"Health Qual Life Outcomes"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279719303989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279719303989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:23:59Z","timestamp":1760927039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279719303989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S1047279719303989"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2019.12.004","relation":{},"ISSN":["1047-2797"],"issn-type":[{"type":"print","value":"1047-2797"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2019.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}